ECJ JUDGE SAYS OFFICIAL EU MEDICINE MARKET APPROVAL CAN OCCUR BEFORE A COUNTRY BECOMES A MEMBER STATE
April 1st, 2011
BY KEITH NUTHALL
A EUROPEAN Court of Justice (ECJ) judge has argued that the date medicine market approvals granted in a European Union (EU) country before they became a member state determine the expiry date of patents across the EU. Generics (UK) Ltd claimed an 1963 Austrian authorisation, which expired in 2001, should be considered as the baseline for a supplementary protection application by Britain's Synaptech Inc for the neuro-muscular medicine Galantamine. It argued that because Austria was not then a member state, a 2000 Swedish market approval decision ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.